Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 12

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

228

HTML

2356

Tables (1-2)

215

Sum=2799

Mar 28, 2008 (publication date) through Jan 22, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Mar 28, 2008; 14(12): 1812-1822
Published online Mar 28, 2008. doi: 10.3748/wjg.14.1812

Table 2 Classification of patients into 3 treatment categories based on CGA

Group	Description	Treatment
1	Healthy, good PS	Standard cancer treatment
2	Partially dependent, ≤ 2 comorbidities
	Life expectancy shortened by cancer
	if can tolerate treatment	Standard cancer treatment
	if cannot tolerate treatment	Palliation
	Life expectancy not shortened by cancer	Palliation
3	Frail patients who are totally dependent with ≥ 3 comorbidities or 1 geriatric syndrome	Palliation

Citation: Rosati G, Bilancia D. Role of chemotherapy and novel biological agents in the treatment of elderly patients with colorectal cancer. World J Gastroenterol 2008; 14(12): 1812-1822
URL: https://www.wjgnet.com/1007-9327/full/v14/i12/1812.htm
DOI: https://dx.doi.org/10.3748/wjg.14.1812